Abstract
Polycystic ovarian syndrome (PCOS) is the most common disorder of the reproductive life, affecting 5-10% of women. The well-documented cardiometabolic manifestations of PCOS are associated with the underlying hyperinsulinemia and the degree of hyperandrogenemia, which are well established in the premenopausal years. A large body of evidence explored whether the cardiovascular risk related to a PCOS diagnosis persists into the postmenopausal years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
